Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?

Rao G, Sonabend A, Heimberger AB.

Neuro Oncol. 2020 Jan 22. pii: noaa018. doi: 10.1093/neuonc/noaa018. [Epub ahead of print] No abstract available.

PMID:
31967642
2.

Temporal Change in Tumor Volume Following Stereotactic Radiosurgery to a Single Brain Metastasis.

Goethe EA, Rao G, Harvey A, Mesfin FB, Li M, Mahajan A, Ye J, Suki D.

World Neurosurg. 2020 Jan 6. pii: S1878-8750(19)33200-0. doi: 10.1016/j.wneu.2019.12.168. [Epub ahead of print] No abstract available.

PMID:
31917308
3.

A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression.

de Almeida Bastos DC, Everson RG, de Oliveira Santos BF, Habib A, Vega RA, Oro M, Rao G, Li J, Ghia AJ, Bishop AJ, Yeboa DN, Amini B, Rhines LD, Tatsui CE.

J Neurosurg Spine. 2020 Jan 3:1-9. doi: 10.3171/2019.10.SPINE19998. [Epub ahead of print]

PMID:
31899882
4.

Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.

de Groot J, Penas-Prado M, Alfaro-Munoz KD, Hunter K, Pei B, O'brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB.

Neuro Oncol. 2019 Nov 22. pii: noz185. doi: 10.1093/neuonc/noz185. [Epub ahead of print]

PMID:
31755915
5.

Longitudinal molecular trajectories of diffuse glioma in adults.

Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, Beroukhim R, Bock C, Brastianos PK, Brat DJ, Brodbelt AR, Bruns AF, Bulsara KR, Chakrabarty A, Chakravarti A, Chuang JH, Claus EB, Cochran EJ, Connelly J, Costello JF, Finocchiaro G, Fletcher MN, French PJ, Gan HK, Gilbert MR, Gould PV, Grimmer MR, Iavarone A, Ismail A, Jenkinson MD, Khasraw M, Kim H, Kouwenhoven MCM, LaViolette PS, Li M, Lichter P, Ligon KL, Lowman AK, Malta TM, Mazor T, McDonald KL, Molinaro AM, Nam DH, Nayyar N, Ng HK, Ngan CY, Niclou SP, Niers JM, Noushmehr H, Noorbakhsh J, Ormond DR, Park CK, Poisson LM, Rabadan R, Radlwimmer B, Rao G, Reifenberger G, Sa JK, Schuster M, Shaw BL, Short SC, Smitt PAS, Sloan AE, Smits M, Suzuki H, Tabatabai G, Van Meir EG, Watts C, Weller M, Wesseling P, Westerman BA, Widhalm G, Woehrer A, Yung WKA, Zadeh G, Huse JT, De Groot JF, Stead LF, Verhaak RGW; GLASS Consortium.

Nature. 2019 Dec;576(7785):112-120. doi: 10.1038/s41586-019-1775-1. Epub 2019 Nov 20.

PMID:
31748746
6.

Impact of Multi-modality Monitoring Using Direct Electrical Stimulation to Determine Corticospinal Tract Shift and Integrity in Tumors using the Intraoperative MRI.

Krivosheya D, Rao G, Tummala S, Kumar V, Suki D, Bastos DCA, Prabhu SS.

J Neurol Surg A Cent Eur Neurosurg. 2019 Oct 28. doi: 10.1055/s-0039-1698383. [Epub ahead of print]

PMID:
31659724
7.

Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT).

Salem U, Kumar VA, Madewell JE, Schomer DF, de Almeida Bastos DC, Zinn PO, Weinberg JS, Rao G, Prabhu SS, Colen RR.

Cancer Imaging. 2019 Oct 15;19(1):65. doi: 10.1186/s40644-019-0250-4. Review.

8.

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors.

Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, Xi L, Jalali A, Magnotti JF, Muzny DM, Doddapaneni H, Sebastian S, Heck KA, Goodman JC, Gopinath SP, Liu Z, Rao G, Plon SE, Yoshor D, Wheeler DA, Zoghbi HY, Klisch TJ.

Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21715-21726. doi: 10.1073/pnas.1912858116. Epub 2019 Oct 7.

PMID:
31591222
9.

Scheduling Neurosurgery Residency Interviews: Avenues for Improvement.

Mummareddy N, Zuckerman SL, Cavallo C, Rao G, Chambless LB.

World Neurosurg. 2019 Oct;130:589-592. doi: 10.1016/j.wneu.2019.07.175. No abstract available.

PMID:
31581408
10.

Predictors of Local Control of Brain Metastasis Treated With Laser Interstitial Thermal Therapy.

Bastos DCA, Rao G, Oliva ICG, Loree JM, Fuentes DT, Stafford RJ, Beechar VB, Weinberg JS, Shah K, Kumar VA, Prabhu SS.

Neurosurgery. 2019 Sep 20. pii: nyz357. doi: 10.1093/neuros/nyz357. [Epub ahead of print]

PMID:
31539421
11.

The CNS Mission and NEUROSURGERY® Publications.

Shupak R, Rao G, Kalkanis SN.

Neurosurgery. 2019 Oct 1;85(4):439-440. doi: 10.1093/neuros/nyz317. No abstract available.

PMID:
31529125
12.

Minimally Invasive Separation Surgery for Metastases in the Vertebral Column: A Technical Report.

Vega RA, Traylor JI, Habib A, Rhines LD, Tatsui CE, Rao G.

Oper Neurosurg (Hagerstown). 2019 Sep 14. pii: opz233. doi: 10.1093/ons/opz233. [Epub ahead of print]

PMID:
31529099
13.

Laser Interstitial Thermal Therapy to the Posterior Fossa: Challenges and Nuances.

Traylor JI, Patel R, Habib A, Muir M, de Almeida Bastos DC, Rao G, Prabhu SS.

World Neurosurg. 2019 Dec;132:e124-e132. doi: 10.1016/j.wneu.2019.08.242. Epub 2019 Sep 10.

PMID:
31518744
14.

Letter: Congress of Neurological Surgeons Female International Think Tank Report: Much Progress, Still Work to Be Done.

Sweet JA, Holanda VM, Rao G, Kalkanis SN, Sharan AD, Benzil DL.

Neurosurgery. 2019 Sep 1;85(3):E599-E606. doi: 10.1093/neuros/nyz254. No abstract available.

PMID:
31418029
15.

Prediction of 1p/19q Codeletion in Diffuse Glioma Patients Using Pre-operative Multiparametric Magnetic Resonance Imaging.

Kim D, Wang N, Ravikumar V, Raghuram DR, Li J, Patel A, Wendt RE 3rd, Rao G, Rao A.

Front Comput Neurosci. 2019 Jul 30;13:52. doi: 10.3389/fncom.2019.00052. eCollection 2019.

16.

Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era.

Bastos DCA, Maldaun MVC, Sawaya R, Suki D, Lang FF, Brown PD, Rao G, Weinberg JS, Prabhu SS.

Neurooncol Pract. 2018 Aug;5(3):161-169. doi: 10.1093/nop/npx033. Epub 2017 Dec 23.

17.

Fractionated stereotactic radiotherapy for local control of resected brain metastases.

Traylor JI, Habib A, Patel R, Muir M, Gadot R, Briere T, Yeboa DN, Li J, Rao G.

J Neurooncol. 2019 Sep;144(2):343-350. doi: 10.1007/s11060-019-03233-9. Epub 2019 Jul 16.

PMID:
31313060
18.

Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.

Chen P, Zhao D, Li J, Liang X, Li J, Chang A, Henry VK, Lan Z, Spring DJ, Rao G, Wang YA, DePinho RA.

Cancer Cell. 2019 Jun 10;35(6):868-884.e6. doi: 10.1016/j.ccell.2019.05.003.

PMID:
31185211
19.

Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.

Patel R, Traylor JI, Latha K, Heimberger AB, Li S, Rao G.

Expert Opin Ther Targets. 2019 Aug;23(8):647-649. doi: 10.1080/14728222.2019.1628220. Epub 2019 Jun 5. No abstract available.

PMID:
31167575
20.

REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.

Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y, Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder S.

Neuro Oncol. 2019 Jun 10;21(6):775-785. doi: 10.1093/neuonc/noz030.

PMID:
30953587
21.

Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons.

North RY, Li Y, Ray P, Rhines LD, Tatsui CE, Rao G, Johansson CA, Zhang H, Kim YH, Zhang B, Dussor G, Kim TH, Price TJ, Dougherty PM.

Brain. 2019 May 1;142(5):1215-1226. doi: 10.1093/brain/awz063.

PMID:
30887021
22.

Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.

Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G, Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R.

Neurosurgery. 2020 Jan 1;86(1):112-121. doi: 10.1093/neuros/nyz008.

PMID:
30799490
23.

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation.

Yan J, Zhao Q, Gabrusiewicz K, Kong LY, Xia X, Wang J, Ott M, Xu J, Davis RE, Huo L, Rao G, Sun SC, Watowich SS, Heimberger AB, Li S.

Nat Commun. 2019 Feb 15;10(1):862. doi: 10.1038/s41467-019-08770-5.

24.

FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation.

Yan J, Zhao Q, Gabrusiewicz K, Kong LY, Xia X, Wang J, Ott M, Xu J, Davis RE, Huo L, Rao G, Sun SC, Watowich SS, Heimberger AB, Li S.

Nat Commun. 2019 Jan 25;10(1):448. doi: 10.1038/s41467-018-08271-x. Erratum in: Nat Commun. 2019 Feb 15;10(1):862.

25.

National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas.

Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ.

World Neurosurg. 2019 Jan 11. pii: S1878-8750(19)30027-0. doi: 10.1016/j.wneu.2018.12.159. [Epub ahead of print]

PMID:
30641236
26.

Correction to: Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapy.

Beechar VB, Prabhu SS, Bastos D, Weinberg JS, Stafford RJ, Fuentes D, Hess KR, Rao G.

J Neurooncol. 2019 Jan;141(2):475. doi: 10.1007/s11060-019-03093-3.

PMID:
30635762
27.

Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study.

Selvarajah D, Wilkinson ID, Fang F, Sankar A, Davies J, Boland E, Harding J, Rao G, Gandhi R, Tracey I, Tesfaye S.

Diabetes. 2019 Apr;68(4):796-806. doi: 10.2337/db18-0509. Epub 2019 Jan 7.

28.

Predictive Value of Preoperative Magnetic Resonance Imaging Findings for Survival and Local Recurrence in Patients Undergoing En Bloc Resection of Sacral Chordomas.

Zuckerman SL, Amini B, Lee SH, Rao G, Tatsui CE, Rhines LD.

Neurosurgery. 2019 Dec 1;85(6):834-842. doi: 10.1093/neuros/nyy578.

PMID:
30541143
29.

Novel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations.

Hewamadduma CA, Hoggard N, O'Malley R, Robinson MK, Beauchamp NJ, Segamogaite R, Martindale J, Rodgers T, Rao G, Sarrigiannis P, Shanmugarajah P, Zis P, Sharrack B, McDermott CJ, Shaw PJ, Hadjivassiliou M.

Neurol Genet. 2018 Oct 24;4(6):e279. doi: 10.1212/NXG.0000000000000279. eCollection 2018 Dec. Erratum in: Neurol Genet. 2018 Dec 03;4(6):e300.

30.

The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.

Latha K, Yan J, Yang Y, Gressot LV, Kong LY, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Eric Davis R, Huang S, Fuller GN, Rao A, Heimberger AB, Li S, Rao G.

J Natl Cancer Inst. 2019 Mar 1;111(3):292-300. doi: 10.1093/jnci/djy107.

31.

Rethinking medulloblastoma from a targeted therapeutics perspective.

Hashimoto Y, Penas-Prado M, Zhou S, Wei J, Khatua S, Hodges TR, Sanai N, Xiu J, Gatalica Z, Kim L, Kesari S, Rao G, Spetzler D, Heimberger A.

J Neurooncol. 2018 Sep;139(3):713-720. doi: 10.1007/s11060-018-2917-2. Epub 2018 Jun 5.

32.

Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.

Tiwary S, Morales JE, Kwiatkowski SC, Lang FF, Rao G, McCarty JH.

Sci Rep. 2018 May 29;8(1):8267. doi: 10.1038/s41598-018-26636-6.

33.

Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.

Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger AB.

Oncoimmunology. 2018 Jan 16;7(4):e1412909. doi: 10.1080/2162402X.2017.1412909. eCollection 2018.

34.

Porphyria: often discussed but too often missed.

O'Malley R, Rao G, Stein P, Bandmann O.

Pract Neurol. 2018 Oct;18(5):352-358. doi: 10.1136/practneurol-2017-001878. Epub 2018 Mar 14. Review.

PMID:
29540448
35.

Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors.

Prayongrat A, Tao R, Allen PK, Guha N, Rao G, Zhao Z, Li J, Brown PD, McGovern SL.

Neurooncol Pract. 2018 Mar;5(1):37-45. doi: 10.1093/nop/npx009. Epub 2017 May 25.

36.

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD, Gumin J, Vence LM, Wistuba I, Rodriguez-Canales J, Villalobos PA, Dirven CMF, Tejada S, Valle RD, Alonso MM, Ewald B, Peterkin JJ, Tufaro F, Fueyo J.

J Clin Oncol. 2018 May 10;36(14):1419-1427. doi: 10.1200/JCO.2017.75.8219. Epub 2018 Feb 12.

37.

Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.

Dextraze K, Saha A, Kim D, Narang S, Lehrer M, Rao A, Narang S, Rao D, Ahmed S, Madhugiri V, Fuller CD, Kim MM, Krishnan S, Rao G, Rao A.

Oncotarget. 2017 Dec 5;8(68):112992-113001. doi: 10.18632/oncotarget.22947. eCollection 2017 Dec 22.

38.

A heterogeneous tissue model for treatment planning for magnetic resonance-guided laser interstitial thermal therapy.

Mitchell D, Fahrenholtz S, MacLellan C, Bastos D, Rao G, Prabhu S, Weinberg J, Hazle J, Stafford J, Fuentes D.

Int J Hyperthermia. 2018 Nov;34(7):943-952. doi: 10.1080/02656736.2018.1429679. Epub 2018 Feb 5.

PMID:
29343140
39.

DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.

Li Y, North RY, Rhines LD, Tatsui CE, Rao G, Edwards DD, Cassidy RM, Harrison DS, Johansson CA, Zhang H, Dougherty PM.

J Neurosci. 2018 Jan 31;38(5):1124-1136. doi: 10.1523/JNEUROSCI.0899-17.2017. Epub 2017 Dec 18.

40.

Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.

Narang S, Kim D, Aithala S, Heimberger AB, Ahmed S, Rao D, Rao G, Rao A.

Oncotarget. 2017 Sep 5;8(60):101244-101254. doi: 10.18632/oncotarget.20643. eCollection 2017 Nov 24.

41.

Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapy.

Beechar VB, Prabhu SS, Bastos D, Weinberg JS, Stafford RJ, Fuentes D, Hess KR, Rao G.

J Neurooncol. 2018 Mar;137(1):57-65. doi: 10.1007/s11060-017-2694-3. Epub 2017 Dec 4. Erratum in: J Neurooncol. 2019 Jan;141(2):475.

42.

Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.

Goethe E, Carter BZ, Rao G, Pemmaraju N.

J Neurooncol. 2018 Jan;136(2):223-231. doi: 10.1007/s11060-017-2676-5. Epub 2017 Dec 1. Review.

PMID:
29196926
43.

Imaging muscle as a potential biomarker of denervation in motor neuron disease.

Jenkins TM, Alix JJP, David C, Pearson E, Rao DG, Hoggard N, O'Brien E, Baster K, Bradburn M, Bigley J, McDermott CJ, Wilkinson ID, Shaw PJ.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):248-255. doi: 10.1136/jnnp-2017-316744. Epub 2017 Oct 31.

44.

Interbody distraction and vertebral body reconstruction with polymethylmethacrylate for the treatment of pathological fractures.

Zuckerman SL, Rao G, Rhines LD, McCutcheon IE, Everson RG, Tatsui CE.

J Neurosurg Spine. 2017 Dec;27(6):700-708. doi: 10.3171/2017.4.SPINE161182. Epub 2017 Oct 6.

PMID:
28984511
45.

Preface.

Elder JB, Rao G.

Neurosurg Clin N Am. 2017 Oct;28(4):xiii. doi: 10.1016/j.nec.2017.07.001. Epub 2017 Aug 12. No abstract available.

PMID:
28917292
46.

Intraoperative MRI and Maximizing Extent of Resection.

Rao G.

Neurosurg Clin N Am. 2017 Oct;28(4):477-485. doi: 10.1016/j.nec.2017.05.003. Epub 2017 Jul 23. Review.

PMID:
28917277
47.

A methodology for thermal dose model parameter development using perioperative MRI.

MacLellan CJ, Fuentes D, Prabhu S, Rao G, Weinberg JS, Hazle JD, Stafford RJ.

Int J Hyperthermia. 2018 Sep;34(6):687-696. doi: 10.1080/02656736.2017.1363418. Epub 2017 Aug 22.

PMID:
28830311
48.

Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.

Glitza IC, Guha-Thakurta N, D'Souza NM, Amaria RN, McGovern SL, Rao G, Li J.

Melanoma Res. 2017 Dec;27(6):580-584. doi: 10.1097/CMR.0000000000000389.

PMID:
28817446
49.

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.

Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G.

Lancet Oncol. 2017 Aug;18(8):1040-1048. doi: 10.1016/S1470-2045(17)30414-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433. Lancet Oncol. 2017 Sep;18(9):e510.

50.

Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery.

Cata JP, Bhavsar S, Hagan KB, Arunkumar R, Grasu R, Dang A, Carlson R, Arnold B, Popat K, Rao G, Potylchansky Y, Lipski I, Ratty S, Nguyen AT, McHugh T, Feng L, Rahlfs TF.

J Clin Neurosci. 2017 Sep;43:224-228. doi: 10.1016/j.jocn.2017.05.004. Epub 2017 Jun 7.

PMID:
28601568

Supplemental Content

Loading ...
Support Center